Edgen Stock·Oct 09 2025, 15:06戻る
戻る
Novo Nordisk to Acquire Akero Therapeutics, Bolstering MASH Pipeline
Edgen Stock·Oct 09 2025, 15:06
[1] Novo Nordisk A/S (NVO) M&A Call Transcript (https://seekingalpha.com/article/4828831-novo ...)[2] Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion (https://vertexaisearch.cloud.google.com/groun ...)[3] Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio - GlobeNewswire (https://vertexaisearch.cloud.google.com/groun ...)